- Published: March 2014
Antithrombotics Market Forecast
- Published: December 2009
The antithrombotics market, comprising anticoagulant and antiplatelet sectors, has grown steadily over the 200408 period to $17 billion. However, this has little to do with a raft of recent launches: Lovenox (enoxaparin, Sanofi-Aventis), Plavix (Sanofi-Aventis and Bristol-Myer's Squibb), warfarin and aspirin collectively occupy 78% of the market by volume, and 69% by value.
Key reasons to purchase this title
- Understand why PLATO and RE-LY stole the limelight at the European Society of Cardiology meeting in 2009.
- Quantify the impact of exclusivity rulings on both Lovenox and Plavix and their successors between now and 2018.
- Compare your views on key marketed and pipeline drugs against our independent drug overviews.